3301 - 3325 of 8654 Results
Title
Year
-
OPENTitle: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylationJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 3Issue #: 8Start Page: e202000768End Page: e202000768Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202000768Best OA location URL: https://www.life-science-alliance.org/content/lsa/3/8/e202000768.full.pdfCitation Count: 105
-
OPENTitle: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated GenesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 17Start Page: 9493End Page: 9493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25179493Best OA location URL: https://doi.org/10.3390/ijms25179493Citation Count: 0
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082617Citation Count: 36
-
OPENTitle: The deterministic role of 5-mers in microRNA-gene targetingJournal Name: RNA BiologyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2018.1462652Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2018.1462652?needAccess=trueCitation Count: 16
- Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study2019OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 85
-
RESTRICTEDTitle: Improving anxiety in Parkinson's disease: A cautionary tale about mobile health technologiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 50End Page: 51Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.010Citation Count: 6
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 90
- Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia2016OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://lup.lub.lu.se/record/8592864Citation Count: 24
- Longitudinal relationships between depressive symptoms, functional impairment, and physical activity in later late life2024RESTRICTEDTitle: Longitudinal relationships between depressive symptoms, functional impairment, and physical activity in later late lifeJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 47Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11357-024-01282-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11872875Citation Count: 2
- Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level2019OPENTitle: Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient levelJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 22Issue #:Start Page: 101720End Page: 101720Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101720Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101720Citation Count: 46
- Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variant2025OPENTitle: Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variantJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci190017Best OA location URL: https://doi.org/10.1172/jci190017Citation Count: 0
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat2015RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 73
- Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy Controls2019OPENTitle: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy ControlsJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 13Issue #: 17Start Page: 1447End Page: 1457Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2019-0315Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2019-0315Citation Count: 35
- Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation2022OPENTitle: Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 21Start Page: 3613End Page: 3628Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac035Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddac035/42548512/ddac035.pdfCitation Count: 25
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease2023OPENTitle: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 704End Page: 717Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11481-023-10094-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-023-10094-7.pdfCitation Count: 5
-
RESTRICTED
-
OPENTitle: Personalised regional modelling predicts tau progression in the human brainJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 23Issue #: 7Start Page: e3003241End Page: e3003241Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3003241Best OA location URL: https://doi.org/10.1371/journal.pbio.3003241Citation Count: 0
-
RESTRICTEDTitle: Association Between Pathology and Electroencephalographic Activity in Parkinson’s DiseaseJournal Name: Clinical EEG and NeurosciencePublisher: SAGE PublicationsVol: 49Issue #: 5Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1550059417696179Citation Count: 11
- Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease2014OPENTitle: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2014Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/606427Best OA location URL: https://downloads.hindawi.com/journals/pd/2014/606427.pdfCitation Count: 25
- Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time window2016RESTRICTEDTitle: Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time windowJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 234Issue #: 7Start Page: 1787End Page: 1794Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-016-4578-8Citation Count: 32
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 36
- Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats2021OPENTitle: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in ratsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-85293-4Best OA location URL: https://www.nature.com/articles/s41598-021-85293-4.pdfCitation Count: 14
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://hal.science/hal-04247698Citation Count: 249
- Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s Disease2023OPENTitle: Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 343End Page: 343Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells12030343Best OA location URL: https://www.mdpi.com/2073-4409/12/3/343/pdf?version=1674009937Citation Count: 5